|
|
|
| Efficacy of unilateral ilioinguinal transversus abdominis plane block for alleviation of catheter-related bladder discomfort in male patients after emergence from general anesthesia: a prospective, randomized controlled trial |
| ZHAO Xiyue1, CHEN Lei1, QIU Lili1, HU Yi1, ZHUANG Guiquan2, WANG Mengjia2, WANGLiangrong1. |
| 1.Department of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325015, China; 2.The First School of Medicine, School of Information and Engineering, Wenzhou Medical University, Wenzhou 325035, China |
|
| Cite this article: |
|
ZHAO Xiyue,CHEN Lei,QIU Lili1, et al. Efficacy of unilateral ilioinguinal transversus abdominis plane block for alleviation of catheter-related bladder discomfort in male patients after emergence from general anesthesia: a prospective, randomized controlled trial[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2022, 52(5): 394-398.
|
|
|
|
Abstract Objective: To investigate urinary catheterization frequently leading to catheter-related bladder discomfort (CRBD) in male patients after general anesthesia, and to prove the efficacy of unilateral ilioinguinal transversus abdominis plane block (TAPB) in attenuating CRBD in male patients. Methods: Male patients with a severe CRBD were randomized to receive unilateral ilioinguinal TAPB with 0.375% ropivacaine 10 mL (group T) or intravenous sufentanil 0.15 μg/kg (group C). The primary outcomes were the severity of CRBD at 0.5,1, 2, and 6 hours after treatment, and the other outcomes included the postoperative adverse events related to treatments. In addition, postoperative pain and need for analgesic drug were recorded. Tramadol was given to patients with moderate to severe CRBD. The findings were compared between the two Groups. Results: The incidence of moderate-to-severe CRBD in group T was significantly lower than in group C at 0.5, 1, 2, and 6 hours after treatment. The need for tramadol in Group T was significantly less than Group C (P<0.05). The postoperative incidences of sedation and respiratory depression were decreased significantly in group T, compared with group C (P<0.05). Conclusion: Unilateral ilioinguinal TAPB with ropivacaine could decrease the severity of CRBD and reduce the need for rescue agent. It could also reduce the incidence of agent-related complications in male patients after general anesthesia as compared with the therapy of intravenous sufentanil.
|
|
Received: 27 January 2022
|
| |
|
|
|
|
|
|
